000			02184 a2200637 4500
005			20250516230051.0
264		0	_c20151012
008			201510s 0 0 eng d
022			_a1502-7708
024	7		_a10.3109/00365521.2014.946082 _2doi
040			_aNLM _beng _cNLM
100	1		_aHiroz, Philippe
245	0	0	_aAnalysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort. _h[electronic resource]
260			_bScandinavian journal of gastroenterology _cOct 2014
300			_a1207-18 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdalimumab
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBody Mass Index
650	0	4	_aCertolizumab Pegol
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCohort Studies
650	0	4	_aColitis, Ulcerative _xdiagnosis
650	0	4	_aCrohn Disease _xdiagnosis
650	0	4	_aDelayed Diagnosis
650	0	4	_aDrug Substitution _xstatistics & numerical data
650	0	4	_aDrug Tolerance
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aInfant
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aRisk Factors
650	0	4	_aSwitzerland
650	0	4	_aTime Factors
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aYoung Adult
700	1		_aVavricka, Stephan R
700	1		_aFournier, Nicolas
700	1		_aSafroneeva, Ekaterina
700	1		_aPittet, Valérie
700	1		_aRogler, Gerhard
700	1		_aSchoepfer, Alain M
773	0		_tScandinavian journal of gastroenterology _gvol. 49 _gno. 10 _gp. 1207-18
856	4	0	_uhttps://doi.org/10.3109/00365521.2014.946082 _zAvailable from publisher's website
999			_c24095124 _d24095124